01
Pharmaceuticals · Cross-border M&A
EUR 180M European acquisition for a leading Indian pharmaceutical group.
Comprehensive financial, commercial and technical due diligence plus independent valuation — completed in 9 weeks across three jurisdictions.
EUR 180M
Transaction value